By Adria Calatayud

 

Koninklijke Philips NV said Monday that it is starting a recall notification for the U.S. in relation to certain sleep and respiratory-care devices, leading it to book 250 million euros ($302.8 million) in additional costs.

The Dutch medical-technology company said it identified potential health risks related to a sound-abatement foam component in certain devices. The majority of the affected devices are in the first-generation DreamStation sleep and respiratory-care product family, the company said.

Philips issued a recall notification for the U.S. and a field-safety notice for the rest of the world in consultation with regulatory agencies.

The company said it will replace the current sound-abatement foam with a new material and modify the first-generation DreamStation product families with a different foam.

As a result, Philips said it expects an increase of EUR250 million in costs, in addition to the provision of EUR250 million it booked in its first-quarter results.

However, the company said its 2021 guidance for adjusted earnings before interest, taxes and amortization margin and comparable sales growth remains unchanged as revenue headwinds in the sleep and respiratory-care business will be offset by strength in other segments.

 

Write to Adria Calatayud at adria.calatayud@dowjones.com

 

(END) Dow Jones Newswires

June 14, 2021 02:33 ET (06:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Koninklijke Philips NV Charts.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Koninklijke Philips NV Charts.